NUTRIEN LTD (NTR) Stock Analyst Ratings
NYSE:NTR - New York Stock Exchange, Inc. - CA67077M1086 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 75% to NTR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 44.19. This target is -23.09% below the current price.
NTR was analyzed by 26 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about NTR.
In the previous month the buy percentage consensus was at a similar level.
NTR was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-14 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
| 2025-05-14 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-14 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-12 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-09 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-05-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-16 | UBS | Maintains | Neutral -> Neutral |
| 2025-03-13 | Goldman Sachs | Initiate | Sell |
| 2025-03-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-25 | CIBC | Maintains | Outperformer -> Outperformer |
| 2025-02-24 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-24 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-02-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-20 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-02-20 | UBS | Maintains | Neutral -> Neutral |
| 2025-02-10 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-01-28 | UBS | Maintains | Neutral -> Neutral |
| 2025-01-28 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-21 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-01-13 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-01-13 | Piper Sandler | Upgrade | Underweight -> Overweight |
| 2024-12-12 | Oppenheimer | Initiate | Outperform |
| 2024-12-03 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2024-10-10 | UBS | Downgrade | Buy -> Neutral |
| 2024-09-24 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-09-20 | RBC Capital | Reiterate | Outperform -> Outperform |